Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma

International Immunopharmacology

Volumn 2, Issue 10, 2002, Pages 1419-1427

  Takahashi, Eriko ^a   Onda, Kenji ^a   Hirano, Toshihiko ^a   Oka, Kitaro ^a   Maruoka, Noritaka ^b   Tsuyuguchi, Miyako ^b   Matsumura, Yasuhiro ^b   Niitsuma, Tomoyuki ^b   Hayashi, Tohru ^b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bronchial asthma; c fos; c jun; Glucocorticoid response; Glucocorticoid receptor mRNA; Mitogen activated peripheral blood lymphocytes

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ACTIN; CONCANAVALIN A; FLUTICASONE PROPIONATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN C FOS; PROTEIN C JUN;

ADULT; AGED; ARTICLE; ASTHMA; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION; MALE; MONONUCLEAR CELL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; ONCOGENE;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; FEMALE; GENES, FOS; GENES, JUN; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER;

EID: 0036710038     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00083-8     Document Type: Article

References (30)

1. Barnes P.J. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:1995;868-875.
2. Hearing S.D., Norman M., Probert C.S., Haslam N., Dayan C.M. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut. 45:1999;382-388.
3. Briggs W.A., Gimenez L.F., Samaniego-Picota M.et al. Relationship between lymphocyte and clinical steroid responsiveness in focal segmental glomerulosclerosis. J. Clin. Pharmacol. 40:2000;115-123.
4. Hirano T., Oka K., Takeuchi H.et al. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation. 57:1994;1341-1348.
5. Hirano T., Oka K., Takeuchi H.et al. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy. Clin. Pharmacol. Ther. 62:1997;652-664.
6. Kirkham B.W., Corkill M.M., Davison S.C., Panayi G.S. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses. J. Rheumatol. 18:1991;821-825.
7. Corrigan C.J., Brown P.H., Barnes N.C.et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Annu. Rev. Respir. Dis. 144:1991;1016-1025.
8. Corrigan C.J., Brown P.H., Barnes N.C., Tsai J.J., Frew A.J., Kay A.B. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Annu. Rev. Respir. Dis. 144:1991;1026-1032.
9. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Colch). 94:1998;557-572.
10. Barnes P.J. Therapeutic strategies for allergic diseases. Nature. 402:1999;B31-B38.
11. Hollenberg S.M., Weinberger C., Ong E.S.et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
12. Bamberger C.M., Bamberger A.M., de Castro M., Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95:1995;2435-2441.
13. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271:1996;9550-9559.
14. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 274:1999;27857-27866.
15. Hecht K., Carlstedt-Duke J., Stierna P., Gustafsson J., Bronnegard M., Wikstrom A.C. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J. Biol. Chem. 272:1997;26659-26664.
16. Leung D.Y., Hamid Q., Vottero A.et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J. Exp. Med. 186:1997;1567-1574.
17. Shahidi H., Vottero A., Stratakis C.A.et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254:1999;559-565.
18. Honda M., Orii F., Ayabe T.et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 118:2000;859-866.
19. Adcock I.M., Lane S.J., Brown C.R., Lee T.H., Barnes P.J. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J. Exp. Med. 182:1995;1951-1958.
20. Hirano T., Oka K., Umezawa Y., Hirata M., Oh-i T., Koga M. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis. Clin. Pharmacol. Ther. 63:1998;465-470.
21. Hirano T., Akashi T., Keira T., Oka K., Ihoya N., Yoshida M. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clin. Pharmacol. Ther. 68:2000;532-540.
22. Sumida A., Kinoshita K., Fukuda T.et al. Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver. Biochem. Biophys. Res. Commun. 262:1999;499-503.
23. Gagliardo R., Chanez P., Vignola A.M.et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am. J. Respir. Crit. Care Med. 162:2000;7-13.
24. Leung D.Y., Martin R.J., Szefler S.J.et al. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181:1995;33-40.
25. Sousa A.R., Lane S.J., Soh C., Lee T.H. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. J. Allergy Clin. Immunol. 104:1999;565-574.
26. Lane S.J., Adcock I.M., Richards D., Hawrylowicz C., Barnes P.J., Lee T.H. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J. Clin. Invest. 102:1998;2156-2164.
27. Sousa A.R., Lane S.J., Cidlowski J.A., Staynov D.Z., Lee T.H. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J. Allergy Clin. Immunol. 105:2000;943-950.
28. Sher E.R., Leung D.Y., Surs W.et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. 93:1994;33-39.
29. Vachier I., Chiappara G., Vignola A.M.et al. Glucocorticoid receptors in bronchial epithelial cells in asthma. Am. J. Respir. Crit. Care Med. 158:1998;963-970.
30. Foletta V.C., Segal D.H., Cohen D.R. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63:1998;139-152.